annual net income:
$4.41B+$459.00M(+11.61%)Summary
- As of today (June 23, 2025), REGN annual net profit is $4.41 billion, with the most recent change of +$459.00 million (+11.61%) on December 31, 2024.
- During the last 3 years, REGN annual net income has fallen by -$3.66 billion (-45.36%).
- REGN annual net income is now -45.36% below its all-time high of $8.08 billion, reached on December 31, 2021.
Performance
REGN Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$808.70M-$109.00M(-11.88%)Summary
- As of today (June 23, 2025), REGN quarterly net profit is $808.70 million, with the most recent change of -$109.00 million (-11.88%) on March 31, 2025.
- Over the past year, REGN quarterly net income has increased by +$86.70 million (+12.01%).
- REGN quarterly net income is now -73.90% below its all-time high of $3.10 billion, reached on June 30, 2021.
Performance
REGN quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$4.50B+$86.70M(+1.96%)Summary
- As of today (June 23, 2025), REGN TTM net profit is $4.50 billion, with the most recent change of +$86.70 million (+1.96%) on March 31, 2025.
- Over the past year, REGN TTM net income has increased by +$641.50 million (+16.63%).
- REGN TTM net income is now -44.28% below its all-time high of $8.08 billion, reached on December 31, 2021.
Performance
REGN TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
REGN Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.6% | +12.0% | +16.6% |
| 3 y3 years | -45.4% | -16.9% | -43.3% |
| 5 y5 years | +108.5% | +29.5% | +97.4% |
REGN Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -45.4% | +11.6% | -43.5% | +12.0% | -43.3% | +16.6% |
| 5 y | 5-year | -45.4% | +108.5% | -73.9% | +29.5% | -44.3% | +97.4% |
| alltime | all time | -45.4% | +2089.8% | -73.9% | +1393.8% | -44.3% | +2128.9% |
REGN Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $808.70M(-11.9%) | $4.50B(+2.0%) |
| Dec 2024 | $4.41B(+11.6%) | $917.70M(-31.5%) | $4.41B(-5.2%) |
| Sep 2024 | - | $1.34B(-6.4%) | $4.65B(+7.7%) |
| Jun 2024 | - | $1.43B(+98.4%) | $4.32B(+12.0%) |
| Mar 2024 | - | $722.00M(-37.7%) | $3.86B(-2.4%) |
| Dec 2023 | $3.95B(-8.9%) | $1.16B(+15.1%) | $3.95B(-0.9%) |
| Sep 2023 | - | $1.01B(+4.1%) | $3.99B(-7.2%) |
| Jun 2023 | - | $968.40M(+18.4%) | $4.30B(+2.8%) |
| Mar 2023 | - | $817.80M(-31.7%) | $4.18B(-3.6%) |
| Dec 2022 | $4.34B(-46.3%) | $1.20B(-9.0%) | $4.34B(-19.2%) |
| Sep 2022 | - | $1.32B(+54.4%) | $5.37B(-5.6%) |
| Jun 2022 | - | $852.10M(-12.5%) | $5.69B(-28.3%) |
| Mar 2022 | - | $973.50M(-56.3%) | $7.93B(-1.8%) |
| Dec 2021 | $8.08B(+129.9%) | $2.23B(+36.6%) | $8.08B(+15.4%) |
| Sep 2021 | - | $1.63B(-47.3%) | $7.00B(+12.7%) |
| Jun 2021 | - | $3.10B(+177.9%) | $6.21B(+55.0%) |
| Mar 2021 | - | $1.12B(-3.0%) | $4.00B(+14.0%) |
| Dec 2020 | $3.51B(+66.0%) | $1.15B(+36.5%) | $3.51B(+11.3%) |
| Sep 2020 | - | $842.10M(-6.2%) | $3.16B(+5.8%) |
| Jun 2020 | - | $897.30M(+43.7%) | $2.98B(+30.9%) |
| Mar 2020 | - | $624.60M(-21.1%) | $2.28B(+7.7%) |
| Dec 2019 | $2.12B(-13.4%) | $792.00M(+18.3%) | $2.12B(-1.3%) |
| Sep 2019 | - | $669.60M(+246.8%) | $2.14B(+3.6%) |
| Jun 2019 | - | $193.10M(-58.1%) | $2.07B(-14.8%) |
| Mar 2019 | - | $461.10M(-43.8%) | $2.43B(-0.7%) |
| Dec 2018 | $2.44B(+104.0%) | $820.40M(+38.0%) | $2.44B(+36.0%) |
| Sep 2018 | - | $594.70M(+7.9%) | $1.80B(+13.0%) |
| Jun 2018 | - | $551.40M(+15.4%) | $1.59B(+11.5%) |
| Mar 2018 | - | $478.00M(+175.5%) | $1.43B(+19.1%) |
| Dec 2017 | $1.20B(+33.8%) | $173.51M(-55.3%) | $1.20B(-6.2%) |
| Sep 2017 | - | $388.32M(+0.1%) | $1.28B(+10.7%) |
| Jun 2017 | - | $387.74M(+55.8%) | $1.15B(+19.9%) |
| Mar 2017 | - | $248.93M(-1.6%) | $963.05M(+7.5%) |
| Dec 2016 | $895.50M(+40.8%) | $253.09M(-4.4%) | $895.50M(+12.3%) |
| Sep 2016 | - | $264.80M(+35.0%) | $797.40M(+7.3%) |
| Jun 2016 | - | $196.22M(+8.2%) | $743.00M(+0.2%) |
| Mar 2016 | - | $181.38M(+17.0%) | $741.42M(+16.6%) |
| Dec 2015 | $636.06M(+88.1%) | $154.99M(-26.3%) | $636.06M(+11.4%) |
| Sep 2015 | - | $210.40M(+8.1%) | $571.16M(+28.6%) |
| Jun 2015 | - | $194.64M(+156.0%) | $444.13M(+28.4%) |
| Mar 2015 | - | $76.02M(-15.6%) | $345.84M(+2.3%) |
| Dec 2014 | $338.13M(-18.3%) | $90.09M(+8.1%) | $338.13M(+1.2%) |
| Sep 2014 | - | $83.38M(-13.5%) | $334.21M(-14.8%) |
| Jun 2014 | - | $96.35M(+41.1%) | $392.14M(+2.3%) |
| Mar 2014 | - | $68.31M(-20.7%) | $383.17M(-7.4%) |
| Dec 2013 | $413.74M(-44.9%) | $86.18M(-39.0%) | $413.74M(-48.2%) |
| Sep 2013 | - | $141.31M(+61.7%) | $797.96M(-5.9%) |
| Jun 2013 | - | $87.38M(-11.6%) | $848.13M(+1.3%) |
| Mar 2013 | - | $98.87M(-79.0%) | $837.49M(+11.6%) |
| Dec 2012 | $750.27M(-438.3%) | $470.41M(+145.7%) | $750.27M(+231.4%) |
| Sep 2012 | - | $191.47M(+149.5%) | $226.42M(-925.9%) |
| Jun 2012 | - | $76.74M(+558.7%) | -$27.41M(-83.6%) |
| Mar 2012 | - | $11.65M(-121.8%) | -$166.66M(-24.8%) |
| Dec 2011 | -$221.76M(+112.3%) | -$53.44M(-14.3%) | -$221.76M(+21.2%) |
| Sep 2011 | - | -$62.37M(-0.2%) | -$182.91M(+18.4%) |
| Jun 2011 | - | -$62.51M(+43.9%) | -$154.42M(+31.5%) |
| Mar 2011 | - | -$43.45M(+197.6%) | -$117.39M(+12.4%) |
| Dec 2010 | -$104.47M(+54.0%) | -$14.60M(-56.9%) | -$104.47M(-17.3%) |
| Sep 2010 | - | -$33.88M(+33.0%) | -$126.36M(+35.1%) |
| Jun 2010 | - | -$25.47M(-16.5%) | -$93.50M(+12.7%) |
| Mar 2010 | - | -$30.52M(-16.4%) | -$82.96M(+22.3%) |
| Dec 2009 | -$67.83M(-14.3%) | -$36.49M(+3495.0%) | -$67.83M(+14.4%) |
| Sep 2009 | - | -$1.01M(-93.2%) | -$59.28M(-25.3%) |
| Jun 2009 | - | -$14.94M(-2.9%) | -$79.38M(-4.5%) |
| Mar 2009 | - | -$15.39M(-44.9%) | -$83.13M(+4.8%) |
| Dec 2008 | -$79.13M(-25.1%) | -$27.94M(+32.3%) | -$79.36M(+23.1%) |
| Sep 2008 | - | -$21.11M(+13.0%) | -$64.49M(-18.6%) |
| Jun 2008 | - | -$18.69M(+60.9%) | -$79.22M(-9.3%) |
| Mar 2008 | - | -$11.62M(-11.1%) | -$87.30M(-17.3%) |
| Dec 2007 | -$105.60M | -$13.07M(-63.5%) | -$105.60M(-14.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | -$35.84M(+33.9%) | -$123.50M(+7.3%) |
| Jun 2007 | - | -$26.77M(-10.5%) | -$115.07M(+2.9%) |
| Mar 2007 | - | -$29.92M(-3.4%) | -$111.87M(+9.3%) |
| Dec 2006 | -$102.34M(+7.2%) | -$30.97M(+13.0%) | -$102.34M(+1.3%) |
| Sep 2006 | - | -$27.41M(+16.3%) | -$101.04M(-6.7%) |
| Jun 2006 | - | -$23.58M(+15.7%) | -$108.28M(-3.1%) |
| Mar 2006 | - | -$20.38M(-31.3%) | -$111.70M(+17.0%) |
| Dec 2005 | -$95.45M(-328.9%) | -$29.67M(-14.4%) | -$95.45M(+51.5%) |
| Sep 2005 | - | -$34.65M(+28.3%) | -$62.98M(+59.8%) |
| Jun 2005 | - | -$27.00M(+554.8%) | -$39.41M(+46.2%) |
| Mar 2005 | - | -$4.12M(-247.7%) | -$26.96M(-164.6%) |
| Dec 2004 | $41.70M(-138.8%) | $2.79M(-125.2%) | $41.70M(+113.5%) |
| Sep 2004 | - | -$11.08M(-23.9%) | $19.53M(+509.2%) |
| Jun 2004 | - | -$14.55M(-122.5%) | $3.21M(-125.4%) |
| Mar 2004 | - | $64.53M(-433.0%) | -$12.61M(-88.2%) |
| Dec 2003 | -$107.46M(-13.6%) | -$19.38M(-29.3%) | -$107.25M(-13.2%) |
| Sep 2003 | - | -$27.40M(-9.7%) | -$123.56M(-4.2%) |
| Jun 2003 | - | -$30.36M(+0.8%) | -$128.98M(-0.0%) |
| Mar 2003 | - | -$30.11M(-15.6%) | -$129.04M(+3.8%) |
| Dec 2002 | -$124.38M(+63.3%) | -$35.69M(+8.8%) | -$124.38M(+6.2%) |
| Sep 2002 | - | -$32.82M(+7.9%) | -$117.06M(+12.4%) |
| Jun 2002 | - | -$30.42M(+19.6%) | -$104.18M(+17.6%) |
| Mar 2002 | - | -$25.45M(-10.3%) | -$88.59M(+16.3%) |
| Dec 2001 | -$76.18M(+228.1%) | -$28.38M(+42.4%) | -$76.18M(+35.4%) |
| Sep 2001 | - | -$19.93M(+34.4%) | -$56.26M(+42.6%) |
| Jun 2001 | - | -$14.83M(+13.8%) | -$39.44M(+43.6%) |
| Mar 2001 | - | -$13.04M(+54.2%) | -$27.46M(+26.3%) |
| Dec 2000 | -$23.21M(+0.5%) | -$8.46M(+171.2%) | -$21.75M(+48.0%) |
| Sep 2000 | - | -$3.12M(+9.3%) | -$14.69M(-10.8%) |
| Jun 2000 | - | -$2.85M(-61.0%) | -$16.47M(-23.1%) |
| Mar 2000 | - | -$7.32M(+422.7%) | -$21.42M(-6.9%) |
| Dec 1999 | -$23.10M(+168.6%) | -$1.40M(-71.4%) | -$23.00M(-15.1%) |
| Sep 1999 | - | -$4.90M(-37.2%) | -$27.10M(+14.8%) |
| Jun 1999 | - | -$7.80M(-12.4%) | -$23.60M(+72.3%) |
| Mar 1999 | - | -$8.90M(+61.8%) | -$13.70M(+59.3%) |
| Dec 1998 | -$8.60M(-25.9%) | -$5.50M(+292.9%) | -$8.60M(+230.8%) |
| Sep 1998 | - | -$1.40M(-166.7%) | -$2.60M(-16.1%) |
| Jun 1998 | - | $2.10M(-155.3%) | -$3.10M(-67.4%) |
| Mar 1998 | - | -$3.80M(-860.0%) | -$9.50M(-18.1%) |
| Dec 1997 | -$11.60M(-64.2%) | $500.00K(-126.3%) | -$11.60M(-42.6%) |
| Sep 1997 | - | -$1.90M(-55.8%) | -$20.20M(-25.7%) |
| Jun 1997 | - | -$4.30M(-27.1%) | -$27.20M(-10.8%) |
| Mar 1997 | - | -$5.90M(-27.2%) | -$30.50M(-5.9%) |
| Dec 1996 | -$32.40M(+37.9%) | -$8.10M(-9.0%) | -$32.40M(+0.9%) |
| Sep 1996 | - | -$8.90M(+17.1%) | -$32.10M(+5.9%) |
| Jun 1996 | - | -$7.60M(-2.6%) | -$30.30M(+11.8%) |
| Mar 1996 | - | -$7.80M(0.0%) | -$27.10M(+15.3%) |
| Dec 1995 | -$23.50M(-23.5%) | -$7.80M(+9.9%) | -$23.50M(+9.3%) |
| Sep 1995 | - | -$7.10M(+61.4%) | -$21.50M(+16.8%) |
| Jun 1995 | - | -$4.40M(+4.8%) | -$18.40M(-24.0%) |
| Mar 1995 | - | -$4.20M(-27.6%) | -$24.20M(-21.2%) |
| Dec 1994 | -$30.70M(-23.1%) | -$5.80M(+45.0%) | -$30.70M(-15.7%) |
| Sep 1994 | - | -$4.00M(-60.8%) | -$36.40M(-13.3%) |
| Jun 1994 | - | -$10.20M(-4.7%) | -$42.00M(+1.9%) |
| Mar 1994 | - | -$10.70M(-7.0%) | -$41.20M(+3.5%) |
| Dec 1993 | -$39.90M(+108.9%) | -$11.50M(+19.8%) | -$39.80M(+14.7%) |
| Sep 1993 | - | -$9.60M(+2.1%) | -$34.70M(+12.3%) |
| Jun 1993 | - | -$9.40M(+1.1%) | -$30.90M(+22.6%) |
| Mar 1993 | - | -$9.30M(+45.3%) | -$25.20M(+31.3%) |
| Dec 1992 | -$19.10M(+324.4%) | -$6.40M(+10.3%) | -$19.20M(+28.9%) |
| Sep 1992 | - | -$5.80M(+56.8%) | -$14.90M(+49.0%) |
| Jun 1992 | - | -$3.70M(+12.1%) | -$10.00M(+51.5%) |
| Mar 1992 | - | -$3.30M(+57.1%) | -$6.60M(+50.0%) |
| Dec 1991 | -$4.50M(+36.4%) | -$2.10M(+133.3%) | -$4.40M(+37.5%) |
| Sep 1991 | - | -$900.00K(+200.0%) | -$3.20M(+3.2%) |
| Jun 1991 | - | -$300.00K(-72.7%) | -$3.10M(-13.9%) |
| Mar 1991 | - | -$1.10M(+22.2%) | -$3.60M(+9.1%) |
| Dec 1990 | -$3.30M | -$900.00K(+12.5%) | -$3.30M(+37.5%) |
| Sep 1990 | - | -$800.00K(0.0%) | -$2.40M(+50.0%) |
| Jun 1990 | - | -$800.00K(0.0%) | -$1.60M(+100.0%) |
| Mar 1990 | - | -$800.00K | -$800.00K |
FAQ
- What is Regeneron Pharmaceuticals annual net profit?
- What is the all time high annual net income for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual net income year-on-year change?
- What is Regeneron Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly net income year-on-year change?
- What is Regeneron Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM net income year-on-year change?
What is Regeneron Pharmaceuticals annual net profit?
The current annual net income of REGN is $4.41B
What is the all time high annual net income for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual net profit is $8.08B
What is Regeneron Pharmaceuticals annual net income year-on-year change?
Over the past year, REGN annual net profit has changed by +$459.00M (+11.61%)
What is Regeneron Pharmaceuticals quarterly net profit?
The current quarterly net income of REGN is $808.70M
What is the all time high quarterly net income for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly net profit is $3.10B
What is Regeneron Pharmaceuticals quarterly net income year-on-year change?
Over the past year, REGN quarterly net profit has changed by +$86.70M (+12.01%)
What is Regeneron Pharmaceuticals TTM net profit?
The current TTM net income of REGN is $4.50B
What is the all time high TTM net income for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM net profit is $8.08B
What is Regeneron Pharmaceuticals TTM net income year-on-year change?
Over the past year, REGN TTM net profit has changed by +$641.50M (+16.63%)